# STAT6

## Overview
Signal transducer and activator of transcription 6 (STAT6) is a gene that encodes a transcription factor involved in the signaling pathways of interleukin-4 (IL-4) and interleukin-13 (IL-13), which are critical for immune system regulation. The STAT6 protein is a member of the STAT family of transcription factors, characterized by its role in mediating cytokine signaling and influencing the differentiation of T helper type 2 (Th2) cells, as well as immunoglobulin class switching in B cells (Karpathiou2021STAT6:; Takeda1996Essential). Structurally, STAT6 is a multidomain protein that includes a DNA-binding domain, an SH2 domain, and a transactivation domain, which are essential for its function in gene regulation (Lim2006Structure). The protein's activity is modulated through phosphorylation, enabling its dimerization and nuclear translocation to regulate target gene expression (Lim2006Structure). STAT6 is implicated in various immune-related disorders and cancers, with mutations in the STAT6 gene linked to conditions such as atopic dermatitis and certain lymphomas (Minskaia2023Autosomal; Sharma2022Human).

## Structure
STAT6 is a multidomain protein involved in cytokine signaling, particularly in response to interleukin-4 and interleukin-13. It contains several functional domains, including an N-terminal coiled-coil domain, a DNA-binding domain, a linker domain, an SH2 domain, and a transactivation domain (Lim2006Structure). The transactivation domain of STAT6 includes a crucial LXXLL motif, which mediates interactions with coactivators like NCoA1 (Seitz2008Molecular). 

The molecular structure of STAT6 has been studied using techniques such as NMR and X-ray crystallography. These studies reveal that the STAT6 peptide, particularly residues 783-814, interacts with the NCoA1 PAS-B domain, forming a complex that involves significant α-helical structures (Russo2017Insight). The LXXLL motif within this region folds into an amphipathic alpha helix upon binding, with leucine residues docking into a hydrophobic groove on NCoA1 (Seitz2008Molecular). 

Post-translational modifications of STAT6 include phosphorylation, which is crucial for its activation and dimerization, allowing it to translocate to the nucleus and regulate gene expression (Lim2006Structure). STAT6 also exists in multiple isoforms due to alternative mRNA splicing or post-translational proteolytic processing (Lim2006Structure).

## Function
STAT6 is a transcription factor that plays a pivotal role in the immune system, particularly in the signaling pathways of interleukin-4 (IL-4) and interleukin-13 (IL-13). In healthy human cells, STAT6 is crucial for the differentiation of T helper type 2 (Th2) cells, which are important for humoral immunity and allergic responses (Karpathiou2021STAT6:). Upon activation by IL-4, STAT6 undergoes phosphorylation, dimerizes, and translocates to the nucleus, where it binds to specific DNA sequences to regulate the expression of target genes involved in immune functions (Takeda1996Essential).

In B cells, STAT6 is essential for immunoglobulin class switching to IgE and IgG1, processes that are critical for effective immune responses against extracellular pathogens (Mikita1996Requirements; Goenka2011Transcriptional). STAT6 also influences the expression of cell surface molecules such as MHC II, CD80, and CD86, which are important for antigen presentation (Goenka2011Transcriptional). In macrophages, STAT6 facilitates the IL-4-induced differentiation of M2 macrophages, contributing to anti-inflammatory responses (Karpathiou2021STAT6:).

STAT6's activity is modulated by interactions with other transcription factors, including NF-κB and PU.1, which can either synergize or inhibit its function depending on the context (Goenka2011Transcriptional). This regulatory network underscores STAT6's broad role in modulating immune responses and maintaining immune homeostasis.

## Clinical Significance
Mutations and alterations in the STAT6 gene are associated with several immune-related disorders and cancers. Gain-of-function (GOF) mutations in STAT6, such as c.1144G>C p.E382Q and c.1256A>G p.D419G, have been linked to severe allergic diseases, including early-onset atopic dermatitis, food allergies, eosinophilic asthma, and anaphylaxis (Minskaia2023Autosomal; Sharma2022Human). These mutations result in increased STAT6 activity, leading to enhanced phosphorylation and transcriptional activity, which contributes to the pathogenesis of these conditions (Sharma2022Human).

STAT6 mutations are also implicated in certain lymphomas. The D419H variant, for example, is associated with follicular and diffuse large B-cell lymphoma, suggesting a role in lymphomagenesis (Minskaia2023Autosomal; Morin2016Genetic). These mutations activate the JAK/STAT signaling pathway, which is a potential therapeutic target in these cancers (Morin2016Genetic).

Alterations in STAT6 expression levels can lead to immune dysregulation, contributing to the development of atopic diseases and lymphomas. Elevated STAT6 and phosphorylated STAT6 levels have been observed in cells with GOF mutations, indicating a link between STAT6 overactivity and disease (Minskaia2023Autosomal).

## Interactions
STAT6 interacts with several proteins and nucleic acids, playing a crucial role in transcriptional regulation. It interacts with the coactivators p300/CBP through its transactivation domain (TAD), specifically between amino acids 642-847, which enhances its transcriptional activity. This interaction is essential for STAT6's function in gene regulation and has been confirmed through coimmunoprecipitation experiments (Gingras1999p300CBP).

STAT6 also interacts with the coactivator p100, which acts as a bridging factor between STAT6 and RNA polymerase II, facilitating transcriptional activation. The interaction is mediated by the SN-like domain of p100 and the TAD of STAT6, enhancing STAT6-mediated transcription in response to IL-4 (Yang2002Identification).

Additionally, STAT6 forms complexes with NF-κB proteins, resulting in synergistic activation of transcription for genes containing both STAT6 and NF-κB binding sites. This interaction enhances the DNA binding affinity of STAT6 and is crucial for IL-4-induced transcription (Shen1998Interaction).

STAT6 also interacts with other transcription factors such as Ets-1, PU.1, and BCL-6, which can either synergize or antagonize its effects on gene expression (HEBENSTREIT2006Signaling).


## References


[1. (Minskaia2023Autosomal) Ekaterina Minskaia, Jesmeen Maimaris, Persephone Jenkins, Adriana S. Albuquerque, Ying Hong, Despina Eleftheriou, Kimberly C. Gilmour, Richard Grace, Fernando Moreira, Bodo Grimbacher, Zoe Adhya, Hana Alachkar, Ariharan Anantharachagan, Richard Antrobus, Gururaj Arumugakani, Chiara Bacchelli, Helen Baxendale, Claire Bethune, Shahnaz Bibi, Barbara Boardman, Claire Booth, Michael Browning, Mary Brownlie, Siobhan Burns, Anita Chandra, Hayley Clifford, Nichola Cooper, Sophie Davies, John Dempster, Lisa Devlin, Rainer Doffinger, Elizabeth Drewe, David Edgar, William Egner, Tariq El-Shanawany, Bobby Gaspar, Rohit Ghurye, Kimberley Gilmour, Sarah Goddard, Pavel Gordins, Sofia Grigoriadou, Scott Hackett, Rosie Hague, Lorraine Harper, Grant Hayman, Archana Herwadkar, Stephen Hughes, Aarnoud Huissoon, Stephen Jolles, Julie Jones, Peter Kelleher, Nigel Klein, Taco Kuijpers, Dinakantha Kumararatne, James Laffan, Hana Lango Allen, Sara Lear, Hilary Longhurst, Lorena Lorenzo, Jesmeen Maimaris, Ania Manson, Elizabeth McDermott, Hazel Millar, Anoop Mistry, Valerie Morrisson, Sai Murng, Iman Nasir, Sergey Nejentsev, Sadia Noorani, Eric Oksenhendler, Mark Ponsford, Waseem Qasim, Ellen Quinn, Isabella Quinti, Alex Richter, Crina Samarghitean, Ravishankar Sargur, Sinisa Savic, Suranjith Seneviratne, Carrock Sewall, Fiona Shackley, Ilenia Simeoni, Kenneth G. C. Smith, Emily Staples, Hans Stauss, Cathal Steele, James Thaventhiran, Moira Thomas, Adrian Thrasher, Steve Welch, Lisa Willcocks, Sarita Workman, Austen Worth, Nigel Yeatman, Patrick Yong, Sofie Ashford, John Bradley, Debra Fletcher, Tracey Hammerton, Roger James, Nathalie Kingston, Willem Ouwehand, Christopher Penkett, F. Lucy Raymond, Kathleen Stirrups, Marijke Veltman, Tim Young, Matthew Brown, Naomi Clements-Brod, John Davis, Eleanor Dewhurst, Marie Erwood, Amy Frary, Rachel Linger, Jennifer Martin, Sofia Papadia, Karola Rehnstrom, William Astle, Antony Attwood, Marta Bleda, Keren Carss, Louise Daugherty, Sri Deevi, Stefan Graf, Daniel Greene, Csaba Halmagyi, Matthias Haimel, Fengyuan Hu, Vera Matser, Stuart Meacham, Karyn Megy, Olga Shamardina, Catherine Titterton, Salih Tuna, Ernest Turro, Ping Yu, Julie von Ziegenweldt, Abigail Furnell, Rutendo Mapeta, Simon Staines, Jonathan Stephens, Deborah Whitehorn, Paula Rayner-Matthews, Christopher Watt, Emma C. Morris, and Siobhan O. Burns. Autosomal dominant stat6 gain of function causes severe atopy associated with lymphoma. Journal of Clinical Immunology, 43(7):1611–1622, June 2023. URL: http://dx.doi.org/10.1007/s10875-023-01530-7, doi:10.1007/s10875-023-01530-7. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10875-023-01530-7)

[2. (Goenka2011Transcriptional) Shreevrat Goenka and Mark H. Kaplan. Transcriptional regulation by stat6. Immunologic Research, 50(1):87–96, March 2011. URL: http://dx.doi.org/10.1007/s12026-011-8205-2, doi:10.1007/s12026-011-8205-2. This article has 427 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12026-011-8205-2)

[3. (Lim2006Structure) Cheh Peng Lim and Xinmin Cao. Structure, function, and regulation of stat proteins. Molecular BioSystems, 2(11):536, 2006. URL: http://dx.doi.org/10.1039/b606246f, doi:10.1039/b606246f. This article has 255 citations and is from a peer-reviewed journal.](https://doi.org/10.1039/b606246f)

[4. (HEBENSTREIT2006Signaling) D HEBENSTREIT, G WIRNSBERGER, J HOREJSHOECK, and A DUSCHL. Signaling mechanisms, interaction partners, and target genes of stat6. Cytokine &amp; Growth Factor Reviews, 17(3):173–188, June 2006. URL: http://dx.doi.org/10.1016/j.cytogfr.2006.01.004, doi:10.1016/j.cytogfr.2006.01.004. This article has 242 citations.](https://doi.org/10.1016/j.cytogfr.2006.01.004)

[5. (Seitz2008Molecular) Markus Seitz, Ludovic T. Maillard, Daniel Obrecht, and John A. Robinson. Molecular characterization of the ncoa‐1–stat 6 interaction. ChemBioChem, 9(8):1318–1322, May 2008. URL: http://dx.doi.org/10.1002/cbic.200700773, doi:10.1002/cbic.200700773. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cbic.200700773)

6. (Sharma2022Human) Human Germline Heterozygous Gain-of-Function STAT6 Variants Cause Severe Allergic Disease. This article has 2 citations.

[7. (Mikita1996Requirements) Thomas Mikita, Dayle Campbell, Pengguang Wu, Keith Williamson, and Ulrike Schindler. Requirements for interleukin-4-induced gene expression and functional characterization of stat6. Molecular and Cellular Biology, 16(10):5811–5820, October 1996. URL: http://dx.doi.org/10.1128/mcb.16.10.5811, doi:10.1128/mcb.16.10.5811. This article has 232 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.16.10.5811)

[8. (Shen1998Interaction) Ching-Hung Shen and Janet Stavnezer. Interaction of stat6 and nf-κb: direct association and synergistic activation of interleukin-4-induced transcription. Molecular and Cellular Biology, 18(6):3395–3404, June 1998. URL: http://dx.doi.org/10.1128/mcb.18.6.3395, doi:10.1128/mcb.18.6.3395. This article has 157 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.18.6.3395)

[9. (Karpathiou2021STAT6:) Georgia Karpathiou, Alexandra Papoudou-Bai, Elise Ferrand, Jean Marc Dumollard, and Michel Peoc’h. Stat6: a review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology. Pathology - Research and Practice, 223:153477, July 2021. URL: http://dx.doi.org/10.1016/j.prp.2021.153477, doi:10.1016/j.prp.2021.153477. This article has 47 citations.](https://doi.org/10.1016/j.prp.2021.153477)

[10. (Gingras1999p300CBP) S. Gingras, J. Simard, B. Groner, and E. Pfitzner. P300/cbp is required for transcriptional induction by interleukin-4 and interacts with stat6. Nucleic Acids Research, 27(13):2722–2729, July 1999. URL: http://dx.doi.org/10.1093/nar/27.13.2722, doi:10.1093/nar/27.13.2722. This article has 108 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/27.13.2722)

[11. (Morin2016Genetic) Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri, Rebecca L. Johnston, Lauren Chong, Jasleen Grewal, Stephen Yu, Daniel Fornika, Kevin Bushell, Torsten Holm Nielsen, Tina Petrogiannis-Haliotis, Michael Crump, Axel Tosikyan, Bruno M. Grande, David MacDonald, Caroline Rousseau, Maryam Bayat, Pierre Sesques, Remi Froment, Marco Albuquerque, Yury Monczak, Kathleen Klein Oros, Celia Greenwood, Yasser Riazalhosseini, Madeleine Arseneault, Errol Camlioglu, André Constantin, Qiang Pan-Hammarstrom, Roujun Peng, Koren K. Mann, and Nathalie A. Johnson. Genetic landscapes of relapsed and refractory diffuse large b-cell lymphomas. Clinical Cancer Research, 22(9):2290–2300, May 2016. URL: http://dx.doi.org/10.1158/1078-0432.ccr-15-2123, doi:10.1158/1078-0432.ccr-15-2123. This article has 182 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.ccr-15-2123)

[12. (Russo2017Insight) Luigi Russo, Karin Giller, Edith Pfitzner, Christian Griesinger, and Stefan Becker. Insight into the molecular recognition mechanism of the coactivator ncoa1 by stat6. Scientific Reports, December 2017. URL: http://dx.doi.org/10.1038/s41598-017-17088-5, doi:10.1038/s41598-017-17088-5. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-17088-5)

[13. (Takeda1996Essential) Kiyoshi Takeda, Takashi Tanaka, Wei Shi, Makoto Matsumoto, Masashi Minami, Shin-ichiro Kashiwamura, Kenji Nakanishi, Nobuaki Yoshida, Tadamitsu Kishimoto, and Shizuo Akira. Essential role of stat6 in il-4 signalling. Nature, 380(6575):627–630, April 1996. URL: http://dx.doi.org/10.1038/380627a0, doi:10.1038/380627a0. This article has 1238 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/380627a0)

[14. (Yang2002Identification) J. Yang. Identification of p100 as a coactivator for stat6 that bridges stat6 with rna polymerase ii. The EMBO Journal, 21(18):4950–4958, September 2002. URL: http://dx.doi.org/10.1093/emboj/cdf463, doi:10.1093/emboj/cdf463. This article has 147 citations.](https://doi.org/10.1093/emboj/cdf463)